Gazzaruso Carmine
IRCCS Maugeri Foundation Hospital, Via Aselli 5, 27100 Pavia, Italy.
Expert Rev Cardiovasc Ther. 2006 Mar;4(2):173-80. doi: 10.1586/14779072.4.2.173.
The current review reports recent data available in the literature on the prevalence of erectile dysfunction and the association of erectile dysfunction with overt and silent coronary artery disease in patients with diabetes mellitus. The mechanisms by which erectile dysfunction is associated with coronary artery disease and potential clinical implications of this association have been extensively analysed. In particular, the role of endothelial dysfunction in the pathophysiology of erectile dysfunction and the potential clinical usefulness of erectile dysfunction to identify diabetic patients with silent coronary artery disease have been outlined. Finally, recent guidelines on the treatment of erectile dysfunction with phosphodiesterase-5 inhibitors in diabetic patients with and without coronary artery disease have been reported and discussed.
本综述报告了文献中关于糖尿病患者勃起功能障碍患病率以及勃起功能障碍与显性和隐性冠状动脉疾病之间关联的最新数据。已对勃起功能障碍与冠状动脉疾病相关的机制以及这种关联的潜在临床意义进行了广泛分析。特别概述了内皮功能障碍在勃起功能障碍病理生理学中的作用以及勃起功能障碍对识别患有隐性冠状动脉疾病的糖尿病患者的潜在临床用途。最后,报告并讨论了近期关于在有或无冠状动脉疾病的糖尿病患者中使用磷酸二酯酶-5抑制剂治疗勃起功能障碍的指南。